In this interview with Oncology Data Advisor, Dr. Joshua Sasine, Hematologist-Oncologist at Cedars-Sinai Medical Center, discusses the factors that make patients suitable candidates for chimeric antigen receptor (CAR) T-cell therapy, strategies to minimize the unique toxicities associated with these treatments, and the future of the use of CAR T-cell therapy in the outpatient setting.
While chimeric antigen receptor (CAR) T–cell therapy has revolutionized the treatment landscape for multiple myeloma, the high demand for these efficacious therapies has made patient selection a challenge. At the recent International Myeloma Society Annual Meeting, Beth Faiman, a Nurse Practitioner at the Cleveland Clinic, presented a poster about a clinical factor scoring system that she and her colleagues have developed to aid in these decisions. In this follow-up interview with Oncology Data Advisor, Dr. Faiman explains how this innovative system works and the next steps to validate it and implement it into practice in the future.
At the recent International Myeloma Society (IMS) Annual Meeting, Dr. Kashyap Patel, CEO of Carolina Blood and Cancer Care Associates and President of the Community Oncology Alliance, spoke about practical solutions for addressing disparities in multiple myeloma in the United States. In this follow-up interview with Oncology Data Advisor, Dr. Patel digs deep into the multifaceted factors that contribute to cancer disparities and shares his pioneering work that aims to ensure that every patient with cancer receives equitable access to care.
In this interview with Oncology Data Advisor, Dr. Valerie Brutus, a Breast Surgical Oncologist at St. Vincent's Medical Center, discusses the significance of Magtrace™, a liquid tracer which has recently become a game changer in guiding surgical decisions for patients with breast cancer.
The Future of MRD in Multiple Myeloma Treatment Decision Making With Rahul Banerjee, MD, and Ben Derman, MD
In this interview, Oncology Data Advisor Editorial Board member Dr. Rahul Banerjee speaks with Dr. Ben Derman, Assistant Professor of Medicine at the University of Chicago, about his research regarding measurable residual disease (MRD) detection in multiple myeloma and its potential role in guiding treatment decisions.
Understanding the Research on Novel Treatments and Nutritional Interventions for Multiple Myeloma With Urvi Shah, MD
During the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Urvi Shah from Memorial Sloan Kettering Cancer Center sat down with Oncology Data Advisor to share her perspectives on the exciting research that was presented in the poster discussion session she chaired on novel therapies for multiple myeloma. In addition, Dr. Shah explains more about her work to impact patients' quality of life and outcomes through nutritional interventions.This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed.
At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Karen Basen-Engquist, PhD, MPH, Director of the Center for Energy Balance in Cancer Prevention and Survivorship at The University of Texas MD Anderson Cancer Center, sat down with Oncology Data Advisor after presenting her education session on behavioral strategies to get your patients with cancer exercising and why it is important.
On August 1st, Oncology Data Advisor hosted a live panel discussion in honor of World Lung Cancer Day, featuring Beth Sandy, MSN, CRNP, and Corey Langer, MD, both of the University of Pennsylvania Abramson Cancer Center. Ms. Sandy and Dr. Langer discussed the improvements in survival that have occurred in recent years due to the development of novel therapies, groundbreaking developments in the fields of immunotherapy and targeted therapy, and exciting advances that lay on the horizon for patients with lung cancer in the coming years.
At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Jeanne Tie spoke with Oncology Data Advisor to share more about her presentation regarding the clinical utility of circulating tumor DNA (ctDNA) analysis to guide treatment decision making for patients with colorectal cancer.
Advancing Treatment for Non–Small Cell Lung Cancer: Exploring the Results of Adagrasib With Alexander Spira, MD, PhD, FACP
At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Alexander Spira, MD, PhD, FACP, Director of the Thoracic and Phase I Program at the Virginia Cancer Specialists, the US Oncology Network, met with Oncology Data Advisor to discuss his presentation about adagrasib for KRAS G12–mutated non–small cell lung cancer with active central nervous system (CNS) metastases.
Following the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Cherry Au, MD, of Rush University Medical Center, spoke with Oncology Data Advisor to discuss her abstract, Medical Student Clinical Cultural Awareness in Cancer Care of Sexual and Gender Minorities.
At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, Dr. Mark T. Fleming and colleagues, from the Virginia Oncology Associates, presented their poster about their initiative to foster a culture of inclusion in an independent community oncology and hematology practice that specializes in the diagnosis and treatment of cancer and blood disorders.
Understanding Bias Experienced by Caregivers Regarding Cancer-Related Decisions With Nick Dionne-Odom, PhD, RN
At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Nick Dionne-Odom, PhD, RN, Assistant Professor in the University of Alabama at Birmingham School of Nursing and School of Geriatric and Palliative Care, presented a poster about his clinical trial exploring cancer-related decisions and the health care team bias experienced by caregivers regarding these decisions. Afterwards, he spoke with Oncology Data Advisor to shed further light on the trial's results.
At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Debra Patt, MD, PhD, MBA, FASCO, Executive Vice President of Texas Oncology and Clinical Professor at Dell Medical School at the University of Texas at Austin, presented her research regarding digital health solutions. Afterwards, she spoke with Oncology Data Advisor to further elucidate on the implications of digital health care for oncology practice.
At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Charles B. Simone, II, MD, FACRO, explained the concepts underlying the treatment of cancer with radiation therapy. In this interview with Oncology Data Advisor, Dr. Simone discusses the different types of radiation treatments and some considerations in choosing treatment. He also shares current evidence from his research about synergy between radiation therapy and checkpoint inhibitors or chemotherapy.
At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, Debra Lundquist, PhD, RN, of Massachusetts General Hospital and colleagues presented their poster that sought to bridge the gap between recent advances in individual therapy which led to improved outcomes and a better understanding of patient-reported hope, quality of life, symptom burden, and coping mechanisms in early phase clinical trial participants.
From the Patient’s Perspective: Improving Quality of Care for the LGBTQIA+ Community With Reverend Sean Parker Dennison
At the recent 47th Annual Oncology Nursing Society (ONS) Congress, Reverend Sean Parker Dennison, alongside three other professionals, held a panel that explored the topic of improving quality of care for LGBTQIA+ individuals with cancer. In this follow-up interview with Oncology Data Advisor, Reverend Sean expands on their thoughts and provides the valuable perspective of their personal experience as a transgender patient in the cancer care community.
At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Joscelyn VanDuren, Family Nurse Practitioner at Advanced Oncology Associates in Alaska, gave a presentation about the challenges faced by patients receiving cancer treatment in rural Alaska and her experiences in treating them. Afterwards, she spoke with Oncology Data Advisor to share additional strategies for nurses and nurse practitioners for providing optimal care for their patients residing in rural areas.
At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Diane Von Ah, Distinguished Professor of Cancer Research at The Ohio State University College of Nursing, gave a presentation about the current state of research regarding cognitive impairment and functional limitation among cancer patients and survivors. In this interview, Dr. Von Ah further expands on her research in this field and explains the role of nurses in improving patients' quality of life both during and after treatment.
At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Bina Parekh, PhD, explained the concept of vicarious trauma and empowered nurses with positive personal growth strategies to deal with challenges, fears, and trauma that stem from dealing with patients with cancer. In this interview with Oncology Data Advisor, Dr. Parekh ...